Large-scale testing (Phase 3)Study completedNCT00556322
What this trial is testing
Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 424